Related Experiment Video

Updated: Jul 15, 2026

Propagating and Detecting an Infectious Molecular Clone of Maedi-visna Virus that Expresses Green Fluorescent Protein
08:49

Propagating and Detecting an Infectious Molecular Clone of Maedi-visna Virus that Expresses Green Fluorescent Protein

Published on: October 9, 2011

[Familial Mediterranean fever: MEFV gene mutations and treatment]

Megumu Saito1, Ryuta Nishikomori, Naotomo Kambe

  • 1Department of Pediatrics, Kyoto University Graduate School of Medicine. msaito@kuhp.kyoto-u.ac.jp

Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology
|May 3, 2007
PubMed

Insights

Familial Mediterranean fever (FMF) is a rare genetic disorder causing recurrent inflammatory attacks. Prompt diagnosis and colchicine treatment are crucial for managing symptoms and preventing severe complications like kidney failure.

Area of Science:

  • Genetics
  • Immunology
  • Rheumatology

Background:

  • Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease.
  • It predominantly affects specific ethnic groups and is rarely reported in Japan.
  • Key features include recurrent fever, serositis (peritonitis, pleuritis, arthritis), and potential complications like AA amyloidosis and renal failure.

Purpose of the Study:

  • To summarize the understanding of Familial Mediterranean fever (FMF).
  • To highlight the genetic basis and clinical manifestations of FMF.
  • To discuss current treatment strategies for FMF.

Main Methods:

  • Literature review of FMF cases and genetic studies.
  • Analysis of clinical symptoms and disease progression.
  • Evaluation of treatment efficacy, particularly colchicine.

Main Results:

  • FMF is caused by mutations in the MEFV gene, affecting the pyrin protein.
  • Pyrin dysregulation leads to excessive pro-inflammatory cytokine production.
  • Colchicine is the primary treatment, effective in symptom management and preventing amyloidosis.

Conclusions:

  • FMF is a genetically determined autoinflammatory condition requiring early intervention.
  • Understanding MEFV gene mutations is key to FMF diagnosis and management.
  • Colchicine therapy remains the cornerstone for controlling FMF and its severe sequelae.

More Related Videos

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Mutations in Microorganisms01:18

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...